BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29879685)

  • 41. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
    Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
    Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
    Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
    Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project.
    Ibarretxe D; Rodríguez-Borjabad C; Feliu A; Bilbao JÁ; Masana L; Plana N
    Atherosclerosis; 2018 Nov; 278():210-216. PubMed ID: 30312929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context.
    Pang J; Martin AC; Bates TR; Hooper AJ; Bell DA; Burnett JR; Norman R; Watts GF
    J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.
    Futema M; Whittall RA; Kiley A; Steel LK; Cooper JA; Badmus E; Leigh SE; Karpe F; Neil HA; ; Humphries SE
    Atherosclerosis; 2013 Jul; 229(1):161-8. PubMed ID: 23669246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
    Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
    Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary.
    Paragh G; Harangi M; Karányi Z; Daróczy B; Németh Á; Fülöp P
    Atherosclerosis; 2018 Oct; 277():262-266. PubMed ID: 30270056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and screening for familial hypercholesterolaemia: finding the patients, finding the genes.
    Bhatnagar D
    Ann Clin Biochem; 2006 Nov; 43(Pt 6):441-56. PubMed ID: 17132275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
    Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia.
    Beheshti S; Madsen CM; Varbo A; Nordestgaard BG
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2657-2667. PubMed ID: 30753598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
    Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
    Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EAS Consensus Panel statement on homozygous FH.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):323-6. PubMed ID: 26247683
    [No Abstract]   [Full Text] [Related]  

  • 53. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
    Ademi Z; Norman R; Pang J; Liew D; Zoungas S; Sijbrands E; Ference BA; Wiegman A; Watts GF
    Atherosclerosis; 2020 Jul; 304():1-8. PubMed ID: 32526542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The diagnostic value of genetic testing in familial hypercholesterolemia in patients with premature myocardial infarction].
    Cui YX; Song JX; Li ZY; Li SF; Liu CF; Chen H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Mar; 52(3):281-285. PubMed ID: 38514330
    [No Abstract]   [Full Text] [Related]  

  • 56. Familial hypercholesterolemia: A systematic review of modeling studies on screening interventions.
    Jahn B; Santamaria J; Dieplinger H; Binder CJ; Ebenbichler C; Scholl-Bürgi S; Conrads-Frank A; Rochau U; Kühne F; Stojkov I; Todorovic J; James L; Siebert U
    Atherosclerosis; 2022 Aug; 355():15-29. PubMed ID: 35870306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simplified Canadian Definition for Familial Hypercholesterolemia.
    Ruel I; Brisson D; Aljenedil S; Awan Z; Baass A; Bélanger A; Bergeron J; Bewick D; Brophy JM; Brunham LR; Couture P; Dufour R; Francis GA; Frohlich J; Gagné C; Gaudet D; Grégoire JC; Gupta M; Hegele RA; Mancini GBJ; McCrindle BW; Pang J; Raggi P; Tu JV; Watts GF; Genest J
    Can J Cardiol; 2018 Sep; 34(9):1210-1214. PubMed ID: 30093300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands.
    Ademi Z; Norman R; Pang J; Sijbrands E; Watts GF; Hutten BA; Wiegman A
    JAMA Pediatr; 2023 Jun; 177(6):625-632. PubMed ID: 37126315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study.
    Casula M; Olmastroni E; Pirillo A; Catapano AL; ; ; ; ; ;
    Atherosclerosis; 2018 Oct; 277():413-418. PubMed ID: 30270079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
    Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.